213 related articles for article (PubMed ID: 20556522)
21. The results of adjuvant radiotherapy in endometrial carcinoma.
Korcum AF; Duman E; Aksu G
Gynecol Endocrinol; 2010 Apr; 26(4):240-5. PubMed ID: 19757242
[TBL] [Abstract][Full Text] [Related]
22. Surgical lymph node assessment influences adjuvant therapy in clinically apparent stage I endometrioid endometrial carcinoma, meeting Mayo criteria for lymphadenectomy.
Pendlebury A; Radeva M; Rose PG
J Surg Oncol; 2021 Apr; 123(5):1292-1298. PubMed ID: 33592112
[TBL] [Abstract][Full Text] [Related]
23. Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma?
Abu-Rustum NR; Iasonos A; Zhou Q; Oke E; Soslow RA; Alektiar KM; Chi DS; Barakat RR
Am J Obstet Gynecol; 2008 Apr; 198(4):457.e1-5; discussion 457.e5-6. PubMed ID: 18395039
[TBL] [Abstract][Full Text] [Related]
24. External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer.
Lin LL; Mutch DG; Rader JS; Powell MA; Grigsby PW
Gynecol Oncol; 2007 Jul; 106(1):215-20. PubMed ID: 17482665
[TBL] [Abstract][Full Text] [Related]
25. Omission of lymphadenectomy is possible for low-risk corpus cancer.
Hidaka T; Kato K; Yonezawa R; Shima T; Nakashima A; Nagira K; Nakamura T; Saito S
Eur J Surg Oncol; 2007 Feb; 33(1):86-90. PubMed ID: 17095180
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of systematic pelvic lymphadenectomy in patients with non-endometrioid endometrial cancers: a retrospective, multicenter study in Korea.
Tong SY; Lee JM; Choi YJ; Lee JK; Kim MK; Cho CH; Kim SM; Park SY; Park CY; Kim KT
J Obstet Gynaecol Res; 2012 Nov; 38(11):1321-7. PubMed ID: 22612243
[TBL] [Abstract][Full Text] [Related]
27. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
Alektiar KM; Venkatraman E; Chi DS; Barakat RR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients.
Chan JK; Cheung MK; Huh WK; Osann K; Husain A; Teng NN; Kapp DS
Cancer; 2006 Oct; 107(8):1823-30. PubMed ID: 16977653
[TBL] [Abstract][Full Text] [Related]
29. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
Ivanov I
Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
[TBL] [Abstract][Full Text] [Related]
30. The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine cancers: a multicenter, retrospective Korean study.
Lee KB; Ki KD; Lee JM; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Jeong DH; Kim KT
Ann Surg Oncol; 2009 Oct; 16(10):2882-7. PubMed ID: 19484311
[TBL] [Abstract][Full Text] [Related]
31. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
32. Can we omit para-aorta lymph node dissection in endometrial cancer?
Tanaka H; Sato H; Miura H; Sato N; Fujimoto T; Konishi Y; Takahashi O; Tanaka T
Jpn J Clin Oncol; 2006 Sep; 36(9):578-81. PubMed ID: 16870694
[TBL] [Abstract][Full Text] [Related]
33. The outcomes of 27,063 women with unstaged endometrioid uterine cancer.
Chan JK; Wu H; Cheung MK; Shin JY; Osann K; Kapp DS
Gynecol Oncol; 2007 Aug; 106(2):282-8. PubMed ID: 17662377
[TBL] [Abstract][Full Text] [Related]
34. Do uterine risk factors or lymph node metastasis more significantly affect recurrence in patients with endometrioid adenocarcinoma?
Nugent EK; Bishop EA; Mathews CA; Moxley KM; Tenney M; Mannel RS; Walker JL; Moore KN; Landrum LM; McMeekin DS
Gynecol Oncol; 2012 Apr; 125(1):94-8. PubMed ID: 22155415
[TBL] [Abstract][Full Text] [Related]
35. Lymphadenectomy influences the utilization of adjuvant radiation treatment for endometrial cancer.
Sharma C; Deutsch I; Lewin SN; Burke WM; Qiao Y; Sun X; Chao CK; Herzog TJ; Wright JD
Am J Obstet Gynecol; 2011 Dec; 205(6):562.e1-9. PubMed ID: 22030315
[TBL] [Abstract][Full Text] [Related]
36. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer.
Cragun JM; Havrilesky LJ; Calingaert B; Synan I; Secord AA; Soper JT; Clarke-Pearson DL; Berchuck A
J Clin Oncol; 2005 Jun; 23(16):3668-75. PubMed ID: 15738538
[TBL] [Abstract][Full Text] [Related]
37. Is a "Puff to the Cuff" enough?: In regard to Alektiar et al. (Int J Radiat Oncol Biol Phys 2005;62: 111-117).
Greven KM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1275; author reply 1275. PubMed ID: 16253783
[No Abstract] [Full Text] [Related]
38. Endometrioid uterine cancer: histopathological risk factors of local and distant recurrence.
Fujimoto T; Nanjyo H; Fukuda J; Nakamura A; Mizunuma H; Yaegashi N; Sugiyama T; Kurachi H; Sato A; Tanaka T
Gynecol Oncol; 2009 Feb; 112(2):342-7. PubMed ID: 19062082
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy?
Beavis AL; Yen TT; Stone RL; Wethington SL; Carr C; Son J; Chambers L; Michener CM; Ricci S; Burkett WC; Richardson DL; Staley AS; Ahn S; Gehrig PA; Torres D; Dowdy SC; Sullivan MW; Modesitt SC; Watson C; Veade A; Ehrisman J; Havrilesky L; Secord AA; Loreen A; Griffin K; Jackson A; Viswanathan AN; Jager LR; Fader AN
Gynecol Oncol; 2020 Mar; 156(3):568-574. PubMed ID: 31948730
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant treatment with concomitant radiotherapy and chemotherapy in high-risk endometrial cancer: a clinical experience.
De Marzi P; Frigerio L; Cipriani S; Parazzini F; Busci L; Carlini L; Viganò R; Mangili G
Gynecol Oncol; 2010 Mar; 116(3):408-12. PubMed ID: 20022359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
